Related references
Note: Only part of the references are listed.A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma
Beatriz Sanchez-Espiridion et al.
BLOOD (2010)
CD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cancer
Monique C. de Jong et al.
CLINICAL CANCER RESEARCH (2010)
Serial Monitoring of Circulating Tumor Cells Predicts Outcome of Induction Biochemotherapy plus Maintenance Biotherapy for Metastatic Melanoma
Kazuo Koyanagi et al.
CLINICAL CANCER RESEARCH (2010)
Evaluation of a 30-Gene Paclitaxel, Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy Response Predictor in a Multicenter Randomized Trial in Breast Cancer
Adel Tabchy et al.
CLINICAL CANCER RESEARCH (2010)
MicroRNAs as therapeutic targets for lung cancer
William C. S. Cho
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Redox protein expression predicts progression-free and overall survival in ovarian cancer patients treated with platinum-based chemotherapy
Caroline M. Woolston et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy
William C. S. Cho
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Conquering Cancer Through Discovery Research
William C. S. Cho
IUBMB LIFE (2010)
Biomarkers as Predictors of Response to Treatment with Motesanib in Patients with Progressive Advanced Thyroid Cancer
Michael B. Bass et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Application of a Filtration- and Isolation-by-Size Technique for the Detection of Circulating Tumor Cells in Cutaneous Melanoma
Vincenzo De Giorgi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Aberrant Fatty Acid-Binding Protein-7 Gene Expression in Cutaneous Malignant Melanoma
Yasufumi Goto et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Is F-18-FDG PET/CT Useful for the Early Prediction of Histopathologic Response to Neoadjuvant Erlotinib in Patients with Non-Small Cell Lung Cancer?
Tjeerd S. Aukema et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
A pathway-based gene signature correlates with therapeutic response in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Zhuang Zuo et al.
MODERN PATHOLOGY (2010)
Expression of concern validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial
David Collingridge
LANCET ONCOLOGY (2010)
High molecular weight-melanoma-associated antigen as a biomarker of desmoplastic melanoma
Yasufumi Goto et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
TIP-1 Translocation onto the Cell Plasma Membrane Is a Molecular Biomarker of Tumor Response to Ionizing Radiation
Hailun Wang et al.
PLOS ONE (2010)
Highly Sensitive Multivariable Assay Detection of Melanocytic Differentiation Antigens and Angiogenesis Biomarkers in Sentinel Lymph Nodes With Melanoma Micrometastases
Dominique Vitoux et al.
ARCHIVES OF DERMATOLOGY (2009)
Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer
A. Daskalaki et al.
BRITISH JOURNAL OF CANCER (2009)
miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer
Elena Gallardo et al.
CARCINOGENESIS (2009)
mRNA Expression and BRAF Mutation in Circulating Melanoma Cells Isolated from Peripheral Blood with High Molecular Weight Melanoma-Associated Antigen-Specific Monoclonal Antibody Beads
Minoru Kitago et al.
CLINICAL CHEMISTRY (2009)
Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study)
Alberto Fusi et al.
EUROPEAN JOURNAL OF CANCER (2009)
Role of miRNAs in lung cancer
William C. S. Cho
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2009)
A simple biological imaging system for detecting viable human circulating tumor cells
Toru Kojima et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer
Nikolaos Xenidis et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy
Magdalena Sarasin-Filipowicz et al.
NATURE MEDICINE (2009)
MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer
Junfang Ji et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prognostic Relevance of Occult Nodal Micrometastases and Circulating Tumor Cells in Colorectal Cancer in a Prospective Multicenter Trial
Kazuo Koyanagi et al.
CLINICAL CANCER RESEARCH (2008)
Share Paper
